SQZ Biotech said today that it closed a $16 million Series B round to fund its preclinical cell therapy programs for oncology and other undisclosed diseases. NanoDimension and Polaris Partners led the funding for the Boston, Mass.-based biotech startup. SQZ said it developed a microchip that can open immune cell membranes temporarily and let proteins in that […]